---
title: "Novavax Inc. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293670486.md"
description: "Novavax Inc. (NVAX) shares fell 1.07% to $7.83 on Thursday, underperforming competitors like Johnson & Johnson, Pfizer, and Merck which all rose. The decline contributed to a second consecutive day of losses for the stock, which is now 34.63% below its 52-week high. Trading volume remained below the 50-day average."
datetime: "2026-07-23T21:28:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293670486.md)
  - [en](https://longbridge.com/en/news/293670486.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293670486.md)
generator: "portal-rs"
---

# Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) shed 1.07% to $7.83 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.15% to 25,137.69 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 34.63% below its 52-week high of $11.97, which the company achieved on February 26th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Pfizer Inc. (PFE) rose 0.77% to $25.01, and Merck & Co. Inc. (MRK) rose 2.36% to $130.48.

Trading volume (2.4 M) remained 2.3 million below its 50-day average volume of 4.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1728ET

### Related Stocks

- [NVAX.US](https://longbridge.com/en/quote/NVAX.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Novavax Partners Receive Approvals For Nuvaxovid Formulation To Target Covid Variant](https://longbridge.com/en/news/297333166.md)
- [Novavax Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/297370908.md)
- [How Is AbbVie’s Stock Performance Compared to Other Healthcare Stocks](https://longbridge.com/en/news/297434315.md)
- [Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors](https://longbridge.com/en/news/297405305.md)
- [The Bull Case For Otis Worldwide (OTIS) Could Change Following Tianjin 117 Sole-Provider Win - Learn Why](https://longbridge.com/en/news/297228522.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**